Ken Griffin Sight Sciences, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$5.49 - $8.31 $148,230 - $224,370
27,000 Added 9000.0%
27,300 $171,000
Q2 2024

Aug 14, 2024
SELL
$5.13 - $7.15 $9,747 - $13,585
-1,900 Reduced 86.36%
300 $2,000
Q1 2024

May 15, 2024
BUY
$4.02 - $5.89 $8,843 - $12,958
2,200 New
2,200 $11,000
Q1 2023

May 15, 2023
BUY
$8.44 - $13.35 $1,688 - $2,670
200 Added 5.26%
4,000 $34,000
Q4 2022

Feb 14, 2023
BUY
$5.58 - $13.94 $21,204 - $52,972
3,800 New
3,800 $46,000

Others Institutions Holding SGHT

# of Institutions
81
Shares Held
21.6M
Call Options Held
66.8K
Put Options Held
13K
View Full List

About Sight Sciences, Inc.

SGHT Quotes by TradingView
  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $170M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email